Natalya Serbina

Natalya Serbina has a diverse work experience spanning multiple companies and roles. Natalya is currently the Director of Biology at TB Alliance, a position they have held since December 2021. Prior to that, they served as a Senior Project Leader from July 2020 to December 2021 and as a Project Leader from January 2019 to July 2020, both at TB Alliance.

Before joining TB Alliance, Natalya worked at Celgene as a Principal Scientist in Translational Development from November 2017 to January 2019. In this role, they served as the immune biomarker lead for clinical trials in multiple myeloma and played a key role in responding to regulatory requests and global submission documents.

Natalya also has experience at Elusys Therapeutics Inc., where they held the position of Principal Scientist in Nonclinical Research and Development from September 2015 to October 2017. Prior to that, they were a Senior Scientist in the same department from October 2011 to September 2015.

Natalya'searly career includes research positions at Memorial Sloan-Kettering Cancer Center. Natalya worked as a Senior Research Scientist from 2007 to 2010, a Research Associate from 2005 to 2007, and a Postdoctoral Fellow from 2001 to 2005.

Overall, Natalya Serbina has a strong background in biology and research, with extensive experience in project leadership, translational development, and nonclinical research and development.

Natalya Serbina earned a Ph.D. in Immunology from the University of Pittsburgh School of Medicine, which they attended from 1994 to 2000. Prior to that, they obtained a B.S. in Biochemistry from the University of Pittsburgh, where they studied from 1991 to 1993. Natalya also has a background in Biology, although specific details about their education in this field are not provided.